Top Tweets for #cantrixil
Today we signed a large-scale manufacturing global agreement with @LonzaGroup, for our ovarian cancer drug candidate, #Cantrixil, as we plan for the initiation of a Phase II clinical trial.
Read the full announcement here:
https://t.co/9IxTDs4sT7
#oncology #biotech
Great to see our development candidate for a hard-to-treat ovarian cancer being recognised in the Australian press, serving as an important reminder that many ovarian cancer patients are still looking for effective treatment options.
https://t.co/RuZOo286ky
#oncology #cantrixil
Our advanced ovarian programme #Cantrixil has been featured in this insightful article in The Canberra Times. Read more here: https://t.co/L8LkXRUtYz
#oncology #ovariancancer #hardtotreatcancer
#Cantrixil targets a wide spectrum of cancer cells, including chemotherapy-resistant tumor-initiating cells that are thought to be responsible for disease relapse. Visit our website to read more about Oasmia’s strategy: https://t.co/U2CQkXKzAQ
On Saturday we hosted Oasmia’s first clinical Advisory Board meeting to discuss the Phase II development of our oncology asset, #Cantrixil. Find out more about Cantrixil on our website here: https://t.co/U2CQkXKzAQ
Our CEO, Francois Martelet, recently spoke to Thomas Nilsson at Aktiespararna to discuss Oasmia’s recent milestones and what to look out for over the next year.
Watch the full interview here: https://t.co/aar1HenQca
#oncology #Aktiespararna #Cantrixil #Apealea
Pleased to share a new research note by @CorporateConne3 following our licensing deal with Oasmia Therapeutics AB $OASM for #Cantrixil. The note says the deal is a “positive event” + proves our “deal making skills to the market”. Read more here: https://t.co/BwrIvmc2O3 $KZA $KZIA

-@KaziaTx is pleased to announce that we have licensed #Cantrixil to Oasmia Pharmaceutical.
-Under the terms of the agreement,Oasmia will make an upfront payment of US$ 4M to $KZIA milestone payments to US$ 42M &double digit royalties on commercial sales
https://t.co/d7ILQpeUoY
Pleased to announce we have licensed #Cantrixil to Oasmia Pharmaceutical $OASM. Oasmia will assume worldwide exclusive rights to develop + commercialise Cantrixil for all indications, with an initial focus on #ovariancancer. Read more here: https://t.co/HdXyXULJBM $KZA $KZIA

We presented new data from our ongoing phase I study of #Cantrixil in #ovariancancer at the @myESMO annual congress. The data showed that the median progression free survival across all 9 patients was 5.5 months. View poster here: https://t.co/I2Y64RTAMW
$KZA$KZIA#ESMO2019#ESMO19

We presented new data from our ongoing phase I study of #Cantrixil in #ovariancancer at the @myESMO annual congress. It showed that of the 9 evaluable patients, 2 were considered to have achieved a ‘partial response’. View poster here: https://t.co/I2Y64RBZom $KZA $KZIA #ESMO2019

We look forward to presenting new data from our ongoing phase I study of #Cantrixil in #ovariancancer at the @myESMO annual congress this weekend. $KZA $KZIA #ESMO2019 #ESMO19

Kazia’s key women, Kate Hill (Company Secretary) and Gabrielle Heaton (Director, Finance and Administration), wore white shirts and teal ribbons in support of #WorldOvarianCancerDay today. We are proud to be working on a potential new treatment for this disease.
#WOCD #Cantrixil

CEO, Dr James Garner discusses the game changing milestones achieved across our clinical programs during FY18, and says the best is ahead of us with high-value data read-outs expected in 2019. $KZA $KZIA #GDC0084 #Cantrixil #oncology #DIPG #brainmets

Kazia CEO Dr James Garner discusses early #Cantrixil ph1 data with Stuart Roberts @Biotech_Buzz : Dose escalation, patient recruitment, emerging results. #ovariancancer $KZA $KZIA https://t.co/yhDD0mLic2
Great to be back at the Gold Coast Investment Showcase with @VEvents_RIU. Our CEO James Garner is presenting our interim
#Cantrixil #ovariancancer data & our progress with #GDC0084 for #glioblastoma brain cancer. View presentation: https://t.co/pO8lfy34ta $KZA $KZIA

#OvarianCancer News Today: 3 Aus #cancer centres spearheading 1st clinical trial of #Cantrixil https://t.co/WoxHYSgQhV
#Cantrixil news via @PharmaDispatch 3 Aus treatment centres progressing #OvarianCancer therapy https://t.co/uU93JVb0V3
NEWS via @wf_laboratory Aus specialists may hold key to #ovariancancer treatment #Cantrixil https://t.co/i1EEwMpULo
NEWS via @finnewsnetwork - our #Cantrixil trial for #ovariancancer is progressing well https://t.co/Mc4OMlIXVf
Last Seen Hashtags on Sotwe
DLbro
Seen from United States
bennybbc
Seen from United States
RandomChat
Seen from Belarus
SammyHart
Seen from Turkey
fwbสงขลา
Seen from Thailand
ometv #omegle #thundr
Seen from Argentina
ぶっかけ
Seen from Japan
brosis filter:native_video
Seen from Turkey
simge barankoglu
Seen from Turkey
محُُُُارمُُُُ
Seen from France
Trends for you
Most Popular Users

Elon Musk 
@elonmusk
240.5M followers

Barack Obama 
@barackobama
118.7M followers

Cristiano Ronaldo 
@cristiano
114.4M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
98.7M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
91.8M followers

KATY PERRY 
@katyperry
90M followers

Taylor Swift 
@taylorswift13
84M followers

Lady Gaga 
@ladygaga
75.5M followers

Virat Kohli 
@imvkohli
73.4M followers

Kim Kardashian 
@kimkardashian
70.8M followers

YouTube 
@youtube
68.7M followers

Neymar Jr 
@neymarjr
66.4M followers

Bill Gates 
@billgates
65.2M followers

Selena Gomez 
@selenagomez
63M followers

The Ellen Show
@theellenshow
62.1M followers

CNN 
@cnn
61.7M followers

X 
@x
60.6M followers


